key: cord-0743521-cm2azbch authors: Finsterer, Josef; Scorza, Fulvio Alexandre; Fiorini, Ana Claudia title: Comments on “CSF-Confirmed SARS-CoV-2 Acute Encephalitis”: SARS-CoV-2-Associated Encephalitis Is Autoimmune Rather Than Infectious date: 2021-12-30 journal: J Clin Neurol DOI: 10.3988/jcn.2022.18.1.102 sha: 0f36f508792dc1f7f7cda7238db163ec557c6141 doc_id: 743521 cord_uid: cm2azbch nan With interest we read the article by Tee et al. 1 about a 69-year-old male with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated encephalitis classified as infectious upon confirmation of the virus in the cerebrospinal fluid (CSF) by PCR. The patient benefited significantly from ceftriaxone, meropenem, favipiravir, dexamethasone, methylprednisolone, clonazepam, valproic acid, and tuberculostatics. 1 Complete recovery was achieved 10 days after the onset of the neurological compromise. 1 The study results are appealing, but they raise several comments and concerns, as detailed below. One serious limitation of the study report is that reference limits for blood and CSF parameters were not provided, which greatly impedes the ability to interpret the results. According to our own laboratory, a cycle threshold of 36.08 for the CSF PCR is normal and does not prove infectivity. Thus, based on the study results, the diagnosis of infectious encephalitis due to infection with SARS-CoV-2 remains unproven. Another limitation is that "results of other CSF analyses" were not specified. 1 It should be reported if investigations for viruses other than SARS-CoV-2 in the CSF were truly negative, if tuberculous meningitis and immune encephalitis were appropriately excluded, and if the CSF was tested for antibodies associated with immune encephalitis. Excluding immune encephalitis is crucial since SARS-CoV-2-associated encephalitis is due to an immune reaction against the virus rather than to a direct viral attack against the central nervous system. 2 Moreover, recovery under steroids suggests immune encephalitis rather than infectious encephalitis. Virostatics are usually ineffective against COVID-19. A further argument for an immune mechanism is that most of the patients with SARS-CoV-2-associated encephalitis were pathophysiologically classified as autoimmune (Table 1) . However, in several cases encephalitis was classified as infectious despite the virus not being reported in the CSF. Though the absence of the virus in the CSF does not generally exclude an infectious pathomechanism, it does make it rather unlikely. A further limitation is that cerebral magnetic resonance imaging (MRI) was not performed on admission. Encephalitis can usually be confirmed on T1-weighted images after administering gadolinium, by the presence of various degrees of focal or global enhancement. MRI performed 1 month after presentation will not reflect the acute disease. Additionally, fluorodeoxyglucose positron-emission tomography may show hypermetabolism within affected areas. 3 Several other cases of SARS-CoV-2-associated infectious encephalitis reported in the literature 4, 5 were not listed in the table of the case report. 1 We do not agree that the case reported by Duong et al. 6 can be classified as infectious encephalitis, since the presence of the virus could not be confirmed in that particular case. A comprehensive workup of the CSF, including a cytokine profile, was also missing. In particu- Acute encephalitis associated with SARS-CoV-2 confirmed in cerebrospinal fluid: first case in Malaysia COVID-19-associated meningoencephalitis: a care report and literature review Postinfectious neurologic complications in COVID-19: a complex case report SARS-CoV-2 RNA detection in cerebrospinal fluid: presentation of two cases and review of literature Case report: detection of SARS-CoV-2 from cerebrospinal fluid in a 34-month-old child with encephalitis Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses Cytokine profiling in Iranian patients with COVID-19; association with clinical severity A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Cerebrospinal fluid confirmed COVID-19-associated encephalitis treated successfully SARS-CoV-2 encephalitis in an adolescent girl Encephalitis associated with COVID-19 infection in an 11-year-old child Encephalitis as a neurological manifestation of COVID-19 Acute meningoencephalitis in a patient with COVID-19 Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature Autoimmune encephalitis secondary to COVID-19 infection Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report Meningo-encephalitis in a middle-aged woman hospitalized for COVID-19 Catatonic syndrome as the presentation of encephalitis in association with COVID-19 Post-infectious rhombencephalitis after coronavirus-19 infection: a case report and literature review N-methyl-d-aspartate receptor encephalitis associated with COVID-19 infection in a toddler Neurologic and radiographic findings associated with COVID-19 infection in children Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease COV-ID-19-induced encephalitis: a case report of a rare presentation with a prolonged electroencephalogram A case report of simultaneous autoimmune and COVID-19 encephalitis